🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We’re excited to feature Resurrect Bio in our expanded edition of Deep Biotech: disruptive innovation for global sustainability report ➡️ deepbiotech.org Resurrect Bio is pioneering a breakthrough approach to precision breeding, dramatically accelerating the discovery of

We have conditionally raised £4.715 million pursuant to a significantly oversubscribed Placing, which was upsized due to strong investor demand, and Subscription which, alongside our existing cash balances, will extend the cash runway to 2027 and will be used to realise the

We are recognising International Clinical Trial Day by celebrating our milestones! We are delighted to share that we have completed: 🔬80+ human challenge trials ✅6,200+ participants enrolled 🟢5,000+ total inoculations We are incredibly proud to have reached such major

#ComingUp: #ONHelix2025 in #Cambridge. Book with BioPartner UK at 10% discount: lnkd.in/eNaNSKhZ #Events2025 #Lifescience

Get BioPartner UK exclusive discount for #NLSDays2025, the premier life science event in the Nordics! Register Now: lnkd.in/eFcnTKDN #Events2025 #Lifescience

Great to see #LifeSciences and #Biotech companies driving innovation in #MedicinesManufacturing to make it more efficient and sustainable 🌱 ➡️ ow.ly/zOCR50VqjRm In this case study, Cytiva explores practical solutions to reduce the carbon footprint and direct freshwater

Our recent announcement on the FDA granting Poolbeg Pharma with Orphan Drug Designation for POLB 001 as an oral preventative therapy for T-cell engager bispecific antibody-induced Cytokine Release Syndrome (CRS) was featured in Drug Discovery World 🤝 FDA grants orphan status to support

Mark your calendars for #NeurologyConference2025 in #Bangkok. Get 15% discount with BioPartner: lnkd.in/ef8Hgx-4 The event will feature plenary lectures, research & technical presentations, and workshops to help shape the future of #neurology & #psychiatry. #Lifescience

An article written by our Principal Scientist was featured in Drug Target Review discussing how POLB 001 has the potential to tackle cancer immunotherapy-induced CRS ⚙️Novel mechanism of action 🏥Implications for healthcare systems 👉Poolbeg's collaborative team environment

#NewMemberAlert Welcome to the BioPartner UK family, Mesenbio We are looking forward to a wonderful #partnership with exciting #opportunities ahead. 🤝 #NewBeginnings #Lifescience #Pharma #Healthcare

The MHRA has updated its guidance on the national assessment procedure for marketing authorisation applications in the UK. For support with your MHRA agency interactions, get in touch to speak to a member of our team: scendea.com/contact - #MHRA

#BIOSPAIN2025 is coming to #Barcelona this October. Huge Discounts Available: lnkd.in/ey8HPW3w BioPartner UK will once again work with the #BritishConsulate to enhance the experience for #UKDelegates with hotels, exhibit offers and more! #BIOSPAIN #Lifescience

🌍 Switzerland, a global biotech hub, will be the guest country at #BIOSPAIN2025. A unique opportunity to strengthen ties between the Swiss and Spanish biotech ecosystems. 🤝 See you in Barcelona! 🔗 asebio.com/en/news-events…

We were featured in a pharmaphorum article on the key takeaways at the LSX Leaders World Congress event in London. 👉 Europe’s biotech sector is adapting, collaborating, and positioning for long-term impact 💬 “This is a resilient industry... there was a sense of ‘we’re all in

Start the summer with AI solutions to power your projects, such as 29% off premium notebooks. Claim your exclusive #memberdiscount coupons to increase your savings! Request your Unique Passcode: [email protected] #MemberOffer #DellOffers

Mark Kotter giving the key note at the #HumanCellForum today in Cambridge UK

Our “laser-focused” efforts for the progression of POLB 001 was featured in a Business Post article. 👉Progressing clinical trial 🔬Interim results expected H1 2026 📈CRS major market opportunity ✅Orphan Drug Designation awarded by FDA 🚀Successful oversubscribed fundraise

Book your ticket w/ BioPartner UK: Get a discounted delegate pass, or join our #UKDelegation to #BIOSPAIN, which includes your delegate pass + hotel and promotion of your company on the #UKPavilion. Register Now: lnkd.in/eAfD7HmB #Events2025 #Lifescience

Relive the best of #LBS25! 2 days of biotech innovation, global networking & bold ideas — all in one place. Watch the highlights now! Save the dates for next edition: 9-10 June 2026 at Excel London. Register your interest: londonbiotechshow.com/register?t=enq… #LondonBiotechShow #LBS2026

Today, Scendea's Chief of Staff, Kat Cash, and Head of CMC, James Parsley, are attending One Nucleus' ON Helix conference. - If you're attending #ONHelix, be sure to connect with the team. Alternatively, get in touch to book a last-minute meeting! scendea.com/contact